Global drive hampered without drugs for "neglected" West and Central Africa
A global drive to help curb the HIV epidemic by 2020 will fail unless millions of people with the virus in West and Central Africa receive life-saving drugs, Medecins Sans Frontieres (MSF) said on Wednesday.
The United Nations AIDS
programme (UNAIDS) launched a five-year treatment programme in 2014 to
ensure that by 2020 almost all people with HIV worldwide know their
status and receive treatment.
The drugs used to treat HIV also help to curb the spread of the virus.
Only
one in four adults and one in 10 children living with HIV in West and
Central Africa have access to antiretroviral (ARV) drugs, compared to
almost half of HIV sufferers in Eastern and Southern Africa, MSF said.
HIV
treatment is not considered a priority in West and Central Africa by
donors or governments, as the region has a smaller percentage of people
infected with HIV than Eastern and Southern Africa, said Mit Philips,
health policy advisor at MSF.
"Donors focus mostly on high prevalence countries, like in Southern Africa, where everyone knows someone affected by HIV," Philips told the Thomson Reuters Foundation by phone from Brussels.
Parts
of Southern Africa have the world's highest HIV rates, including
Swaziland where 27 percent of people aged 15 to 49 have HIV, and South
Africa which has a prevalence rate of nearly 20 percent.
"People
with HIV in West and Central Africa are neglected ... the low
prevalence rate is misleading but means there is a lack of interest and
that the disease is less visible in society," Philips added.
Two
percent of people in West and Central Africa have HIV, yet the region
accounts for one in five new infections annually worldwide, one in four
AIDS-related deaths and almost half of all children born with HIV,
according to MSF.
While conflict across the region
and epidemics of other diseases like Ebola have hindered HIV treatment,
stigma, weak health systems and lack of political will have worsened
the situation, MSF said in a report published on Wednesday.
"Many
people face an obstacle course to obtain ARV drugs - they face stigma
within society and even prejudice from health workers, struggle to pay
transport or consultation fees, and often find there are low stocks of
the drugs," Philips said.
Some 36.9 million
people worldwide are living with HIV, which is spread through blood,
semen and breast milk and causes AIDS, and more than half of them do not
have access to treatment. Many do not know they have the virus.
UNAIDS
said in November that its treatment programme, called 90-90-90, was
starting to show results as the nearly 16 million people being treated
by June 2015 was double the number in 2010.